Clinical Trial Update: High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating high-dose chemotherapy and stem cell transplantation in PET-2 positive Hodgkin's lymphoma after ABVD, with comparison of radiotherapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Hodgkin's Lymphoma | Phase 2, Phase 3 | Status: COMPLETED